Weird How ‘The Worst Kept Secrets’ Are Always About Democrats, Isn’t It?
A Quick Bible Study Vol. 316: The Meaning of Rain in the Eyes...
The Enigma of JD Vance
When 'Just a Game' Isn’t Just a Game Anymore
Two Moments in Annapolis Reveal a Deeper Cultural Drift
The Pope, Iran, and My Being Sentenced to Death As a Christian in...
Grace and Truth: Navigating Conversion Therapy and a Client’s Faith-Based Rights
DEI Over Duty: How the Secret Service Put Identity Politics Above Operational Competence
Leftists Use Russia As an Excuse to Censor Right Wing Media in US...
'No Threat Was Present': Walz's Iran Claim Collides With the Facts
Twice-Deported Illegal Alien Gets 14 Years for Flooding Wisconsin With Cocaine
Washington D.C. Homicides Plunge 52 Percent As National Guard Deployment Changes City's Cr...
Milwaukee Grocery Owner Pleads Guilty to $1.6M SNAP Fraud Scheme
Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness
This Radio Chatter From the Iranian Attack on an Oil Tanker Is Crazy
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement